Heron Therapeutics (HRTX) Amortizatization of Intangibles (2011 - 2026)
Heron Therapeutics (HRTX) reported Amortizatization of Intangibles of $144000.0 for Q1 2026, down 31.75% on a YoY basis from $211000.0 in Q1 2025, and down 39.75% quarter-over-quarter from $239000.0 in Q4 2025.
Heron Therapeutics (HRTX) Amortizatization of Intangibles (2011 - 2026) Analysis & Trends
Heron Therapeutics has reported Amortizatization of Intangibles for 16 years, with the latest figure at $144000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 31.75% year-over-year to $144000.0; the trailing twelve-month figure through Mar 2026 stood at $783000.0 (up 3.3% YoY), and the FY2025 full-year result was $744000.0, down 0.93% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $144000.0, down from $239000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.7 million in Q4 2023, with the low at -$371000.0 in Q2 2023.
- Historically, Amortizatization of Intangibles has averaged $280705.9 across 5 years, with a median of $200000.0 in 2024.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles surged 666.67% — and 2023, when it plunged 3472.73%.
- Heron Therapeutics' Amortizatization of Intangibles stood at $574000.0 in 2022, then surged by 199.3% to $1.7 million in 2023, then slumped by 85.62% to $247000.0 in 2024, then slipped by 3.24% to $239000.0 in 2025, then plunged by 39.75% to $144000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $144000.0 (Q1 2026), $239000.0 (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Heron Therapeutics | 77.43 Mn | 47.47 Mn | 24.07 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144,000.00 |
| Mar 31, 2026 | 144,000.00 |
| Dec 31, 2025 | 239,000.00 |
| Dec 31, 2025 | 239,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 211,000.00 |
| Mar 31, 2025 | 211,000.00 |
| Dec 31, 2024 | 247,000.00 |
| Dec 31, 2024 | 247,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 638,000.00 |
| Mar 31, 2024 | 638,000.00 |
| Dec 31, 2023 | 1.72 Mn |
| Dec 31, 2023 | 1.72 Mn |